Cargando…
A Prospective, Multinational Pharmacoepidemiological Study of Clinical Conversion to Sirolimus Immunosuppression after Renal Transplantation
This prospective pharmacoepidemiological study examined treatment and outcomes in patients converted to sirolimus (SRL) after renal transplantation. 484 subjects in 36 centres in 7 countries were followed for up to 5 years. Principal reasons for conversion were declining graft function (146/484, 30%...
Autores principales: | Kasiske, Bertram L., Nashan, Bjorn, Del Carmen Rial, Maria, Raffaele, Pablo, Russ, Graeme, Campistol, Josep, Pescovitz, Mark D., Keown, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425854/ https://www.ncbi.nlm.nih.gov/pubmed/22934151 http://dx.doi.org/10.1155/2012/107180 |
Ejemplares similares
-
Applying a common data model to Asian databases for multinational pharmacoepidemiologic studies: opportunities and challenges
por: Lai, Edward Chia-Cheng, et al.
Publicado: (2018) -
Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy
por: Foroutan, Naghmeh, et al.
Publicado: (2013) -
Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016) -
Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021) -
Pharmacovigilance and Pharmacoepidemiology
Publicado: (2008)